A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
Launched by UNIVERSITY OF NEBRASKA · Jun 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best ways to distribute fecal immunochemical test (FIT) kits, which help screen for colorectal cancer, especially among African Americans, who often face barriers to screening. The trial will compare two methods: giving out the kits only at a Department of Motor Vehicle (DMV) location versus giving them out at the DMV along with targeted social media ads to raise awareness and encourage more people to participate. The goal is to see which method results in more people returning the tests for screening.
To be part of this study, participants must be African American, aged 45 to 75, and not currently up-to-date with colorectal cancer screenings. Individuals with a history of colorectal cancer or certain related health issues will not be eligible. If you join the study, you will receive a FIT kit at the DMV and, if in the social media group, you will see ads on platforms like Facebook and Instagram encouraging participation. The study aims to enroll 1,200 participants and will track how many return their kits and follow up on any positive results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identification as Black or African American
- • Between 45 and 75 years old
- • Not up-to-date with colorectal cancer (CRC) screening per guidelines
- • Willingness to provide contact information for follow-up
- • Ability to speak, read, and write English
- • Current residency in Douglas County, NE.
- Exclusion Criteria:
- • History of colorectal cancer (CRC)
- • History of adenomas (precancerous polyps) or inflammatory bowel disease
- • Family history of colorectal cancer (CRC)
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Patients applied
Trial Officials
Jungyoon Kim, PhD
Principal Investigator
University of Nebraska
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported